Macleods Pharmaceuticals Pvt Ltd
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Voglimac GM 2 HD Tablet SR is a combination of medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet SR
Voglimac GM 2 HD Tablet SR belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Voglimac GM 2 HD Tablet SR is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Voglimac GM 2 HD Tablet SR.
Voglimac GM 2 HD Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Voglimac GM 2 HD Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Voglimac GM 2 HD Tablet SR is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Voglimac GM 2 HD Tablet SR is a combination medication that contains three active ingredients: Glimepiride, Metformin, and Voglibose. It is used to treat type 2 diabetes mellitus (DM) in adults, in combination with a healthy diet and regular exercise. Glimepiride helps increase insulin production in the pancreas, while Metformin reduces glucose production in the liver and improves insulin sensitivity. Voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose levels. This medication is not suitable for treating type 1 DM.
Common side effects of Voglimac GM 2 HD Tablet SR include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection. If you experience any of these symptoms, consult your doctor or healthcare provider for guidance.
Voglimac GM 2 HD Tablet SR is contraindicated in patients with known allergies to any of its components or excipients. It is also not recommended for patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis. Consult your doctor or healthcare provider before taking this medication if you have any of these conditions.
No, it is not recommended to consume alcohol while taking Voglimac GM 2 HD Tablet SR. This combination may increase the risk of hypoglycemia and lactic acidosis. Avoid drinking alcohol while taking this medication and consult your doctor or healthcare provider if you have any concerns.
Yes, Voglimac GM 2 HD Tablet SR can cause hypoglycemia (low blood sugar). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. This is more likely to occur if you miss or delay meals, drink alcohol, over-exercise, or take other antidiabetic medications. Regularly monitor your blood sugar levels and keep glucose tablets, honey, or fruit juice with you to manage hypoglycemia.
Store Voglimac GM 2 HD Tablet SR in its original packaging, tightly closed. Follow the storage instructions provided on the packaging or label. Dispose of any unused medication and ensure it is not consumed by pets, children, or other individuals.